TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
14.25
+1.12 (8.53%)
Nov 11, 2026, 4:00 PM EST - Market closed
TRex Bio Market Cap
TRex Bio has a market cap or net worth of $383.64 million as of November 11, 2026. It is the 16,334th most valuable company in the world and the 2,933rd biggest in the United States.
Market Cap
383.64M
Enterprise Value
292.98M
1-Year Change
n/a
Global Rank
Country Rank
#2,933 United States
Category
ChartMarket Cap Chart
Since the IPO on October 9, 2026, TRex Bio's market cap has decreased from $384.24M to $383.64M, a decrease of -0.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 383.64M | 8.53% |
| Nov 10, 2026 | 353.49M | -3.38% |
| Nov 9, 2026 | 365.87M | 2.49% |
| Nov 6, 2026 | 356.99M | 2.08% |
| Nov 5, 2026 | 349.72M | -4.13% |
| Nov 4, 2026 | 364.79M | -1.31% |
| Nov 3, 2026 | 369.64M | 0.66% |
| Nov 2, 2026 | 367.22M | -0.73% |
| Oct 30, 2026 | 369.91M | 1.63% |
| Oct 29, 2026 | 363.99M | -6.31% |
| Oct 28, 2026 | 388.48M | 4.64% |
| Oct 27, 2026 | 371.25M | -0.58% |
| Oct 26, 2026 | 373.41M | 0.43% |
| Oct 23, 2026 | 371.79M | -10.90% |
| Oct 22, 2026 | 417.29M | 1.71% |
| Oct 21, 2026 | 410.29M | 5.54% |
| Oct 20, 2026 | 388.75M | -2.43% |
| Oct 19, 2026 | 398.45M | 5.64% |
| Oct 16, 2026 | 377.18M | -1.06% |
| Oct 15, 2026 | 381.22M | 4.89% |
| Oct 14, 2026 | 363.45M | -0.74% |
| Oct 13, 2026 | 366.14M | -3.06% |
| Oct 12, 2026 | 377.72M | -1.70% |
| Oct 9, 2026 | 384.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SL Science Holding | 411.96M |
| Aspen Neuroscience | 401.87M |
| ARS Pharmaceuticals | 397.09M |
| Alector | 391.55M |
| Prelude Therapeutics | 389.32M |
| C4 Therapeutics | 379.51M |
| Altimmune | 375.42M |
| Fennec Pharmaceuticals | 373.11M |